Listar DBBM1 - Artículos por financiación

Mostrando ítems 1-15 de 15

      Financiación
      FEDER/Junta de Andalucía -Consejería de Economía y Conocimiento: MENDO B-CTS-500-UGR18 [1]
      FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento: MENDO (B-CTS-500-UGR18) [1]
      FEDER/Junta de Andalucia-Consejeria de Economia y Conocimiento ROBIN A-CTS-614-UGR20 IRENE P20_00158 [1]
      FEDER/Junta de Andalucia-Consejeria de Economia y Conocimiento: MENDO B-CTS-500-UGR18 Junta de Andalucia PAIDI P20_00158 [1]
      FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento: ROBIN A-CTS-614-UGR20 [1]
      fellowship "Beca de Iniciacion a la Investigacion del Plan Propio de Investigacion 2019" by University of Granada Instituto de Salud Carlos III PT17/0019 [1]
      FIBAO foundation (Granada, Spain) [1]
      Financial support for this work was obtained from the European Research Council (CoG-2014-646903 and PoC-2018-811220) and the Generalitat de Catalunya (SGR330 and PERIS 2017- 2019) to PM, the Spanish Ministry of Economy and Competitiveness (SAF2016-80481-R and SAF2016-76758-R) to PM and IV, the Spanish Association against Cancer (AECCCI- 2015) and Fero Foudation to CB, the Health Institute Carlos III (ISCIII/FEDER, PI17/01028 and PI17/01028) to CB and PJR, the NIHR GOSH BRC and Great Ormond Street Hospital Children's Charity to J.dB, and Bloodwise and Cancer Research UK to BG. RM and PM were also supported by the Deutsche José Carreras Leukämie Stiftung. PM also acknowledges financial support from the Obra Social La Caixa-Fundaciò Josep Carreras. R-T-R is supported by a fellowship from the Spanish Association of Cancer Research (AECC). RV-M is supported by a Torres Quevedo fellowship from the Spanish Ministry of Science and Innovation (PTQ-16-08623). P.M is an investigator of the Spanish Cell Therapy cooperative network (TERCEL). [1]
      Financial support was provided by grant SAF2011-25726 and personal financial support (FPU program) from the Spanish government and also from the Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation & European Regional Development Fund “Una manera de hacer Europa” (ISCIII-RTICC grants RD06/0020/004 and RD06/0020/1019 and BIO2011-27069, MICINN). The authors have also received financial support from the AGAUR-Generalitat de Catalunya (grant 2009SGR1308, 2009 CTP 00026 and Icrea Academia Award 2010 granted to M.C.) and the European Commission (FP7) ETHERPATHS KBBE-grant agreement no. 22263. The authors thank the Bio-NMR EU project (Contract # 261863) for providing NMR access to the HWB-NMR facility. Finally, the authors are grateful for the financial support from Biomaslinic S.L. (Granada, Spain). [1]
      FPU17/01258 fellowship [1]
      FPU19/00576 predoctoral fellowship funded by the Spanish Ministry of Science, Innovation, and Universities [1]
      Fundación Científica de la Asociación Española Contra el Cáncer GCB14-2170 [1]
      Fundacion Progreso y Salud (FPS) [1]
      Fundación Ramon Areces [1]
      Funding for open access charge: Universidad de Almería (Spain)/CBUA [1]